SWOT Analysis and Company Profiles

Chinese Markets for Digestive Remedies: Market Research Report

Chinese Markets for Digestive Remedies

China's demand for Digestive Remedies has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

TABLE OF CONTENTS

I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT

Economic Outlook

Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade

Financial and Tax Regulations

Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. DIGESTIVE REMEDIES INDUSTRY ASSESSMENTS

Digestive Remedies Industry Structure
Market Size
Market Growth Drivers
Digestive Remedies Sales Volume
Major Producer Facility Locations
Major Producers Sales Volume and Market Share
Labor Cost
Potential Entrants
Development Trends
Major Distributors
Major Foreign Investment
Technology Development

IV. DIGESTIVE REMEDIES PRODUCTION AND DEMAND

Digestive System Disorders Overview
Digestive Remedies Market Overview
Chinas Digestive Remedies Market Overview by Classification
Anti-ulcer Drug
Proton Pump Inhibitor Drug
Omeprazole
Lansoprazole
Pantoprazole
Rabeprazole
H2 Receptor Antagonists
Cimetidine
Ranitidine
Famotidine
Developing H2 Receptor Antagonists
Roxatidine
Nizatidine
Lafutidine
Gastric Mucosal Protective Agent
Sucralfate
Bismuth potassium citrate
Ranitidine bismuth citrate
Irritable Bowel Syndrome Drug
Atropine
Diphenoxylate
Sorbitol
Tegaserod
Antiemetic Drug
Diphenhydramine
5-HT3 Receptor Antagonist
Other Drugs
Digestive Remedies Import and Export by Classification
Anti-ulcer Drug Import
Irritable Bowel Syndrome Drug Import
Antiemetic Drug Import
Anti-ulcer Drug Export
Irritable Bowel Syndrome Drug Export
Antiemetic Drug Export

Market Overview by Drugs Active Principle
Market Overview by Producers
Pricing Trend

V. DIGESTIVE REMEDIES MARKET OUTLOOK

Digestive Remedies Markets Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

Read More: Digestive Remedies Market

VI. MARKETING STRATEGIES

China Market Entry Overview

Chinas Distribution System
Digestive Remedies Distribution Channels
Transportation and Freight Infrastructure
Communications

Chinas Market Entry
Export to China
Indirect export
Direct Export
License and Contract Manufacture
Assembling in China
Contract Manufacturing
Trade Permit
Investment
Equity Joint Venture
Contractual Joint Venture
Wholly Foreign-Owned Enterprise

VII. DIGESTIVE REMEDIES PRODUCER DIRECTORY

Profiles of Digestive Remedies Producer

LIST OF TABLES

I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. DIGESTIVE REMEDIES INDUSTRY ASSESSMENTS

Top 10 Digestive Remedies Sales Volume and Market Share in 2008
Digestive Remedies Sales Volume
Major Producer Facility Location
Major Digestive Remedies Producer Sales Volume and Market Share
Major Foreign Investment in China

Read More: Chinese Market

IV. DIGESTIVE REMEDIES PRODUCTION AND DEMAND

Digestive Remedies Sales Volume by Drugs Classification
Digestive Remedies Sales Volume by Classification
Digestive Remedies Import by Drugs Classification
Top 10 Digestive Remedies Sales Volume and Their Market Share
Digestive Remedies Major Producer, Sales Volume, and Market Share in
2008

V. DIGESTIVE REMEDIES MARKET OUTLOOK

Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

Digestive Remedies Sales Volume

II. BUSINESS ENVIRONMENT

Chinas GDP and Growth Rate
Industrial Output by Ownership
Chinas Imports and Exports

III. DIGESTIVE REMEDIES INDUSTRY ASSESSMENTS

Total Digestive Remedies Sales Volume
Digestive Remedies Market by Classification in 2008
Top 10 Digestive Remedies Market Share by Drugs Classification in 2008
Digestive Remedies Sales Volume

IV. DIGESTIVE REMEDIES PRODUCTION AND DEMAND

Digestive Remedies Sales Volume
Digestive Remedies Import Volume
Digestive Remedies Import by Country
Digestive Remedies Export Volume
Digestive Remedies Market Share by Classification in 2008
Anti-Ulcer Drugs Sales Volume and Market Share
Irritable Bowel Syndrome Sales Volume and Market Share
Antiemetic Drug Sales Volume and Market Share
Digestive Remedies Import by Drugs Classification in 2008
Anti-ulcer Drug Import Volume and Market Share
Irritable Bowel Syndrome Drug Import Volume and Market Share
Antiemetic Drug Import Volume and Market Share
Digestive Remedies Export by Drugs Classification in 2008
Anti-ulcer Drug Export Volume and Market Share
Irritable Bowel Syndrome Drug Export Volume and Market Share
Antiemetic Drug Export Volume and Market Share

VI. MARKETING STRATEGIES

Chinas Distribution Channel

To BUY This Report Kindly Visit Us @:

http://www.researchmoz.com/chinese-markets-for-digestive-remedies-report.html

Chinese Markets for Monoclonal Antibody: Market Research Report

Chinese Markets for Monoclonal Antibody

China's demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

TABLE OF CONTENTS

I. INTRODUCTION
Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT
Economic Outlook

Key Economic Indicators
Industrial Output
Population
Foreign Investment
Foreign Trade

Financial and Tax Regulations

Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. MONOCLONAL ANTIBODY INDUSTRY ASSESSMENTS
Monoclonal Antibody Industry Structure
Market Size
Market Growth Drivers
Monoclonal Antibody Sales Volume
Major Producer Facility Locations and Sales Volume
Market Share of Key Producers
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investments
Technology Development

IV. MONOCLONAL ANTIBODY PRODUCTION AND DEMAND
Overview
Demand of Monoclonal Antibody by Region
Monoclonal Antibody Sales Volume
Cancer Treatment Antibody
Autoimmunity Diseases Treatment Antibody
Infection Treatment Antibody
Cardiovascular Diseases Treatment Antibody
Rejection of Organ Transplantation Treatment Antibody
Other Diseases Treatment Antibody
Monoclonal Antibody Imports
Monoclonal Antibody Imports
Cancer Treatment Antibody Import
Autoimmunity Diseases Treatment Antibody Import
Infection Treatment Antibody Import
Cardiovascular Diseases Treatment Antibody Import
Rejection of Organ Transplantation Treatment Antibody Import
Other Diseases Treatment Antibody Import
Pricing Trend

V. MONOCLONAL ANTIBODY MARKET OUTLOOK
Monoclonal Antibody Markets Outlook Overview
Government Regulations
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

Read More: Monoclonal Antibody Market

VI. MARKETING STRATEGIES

China Market Entry Overview

Chinas Distribution System
Monoclonal Antibody Distribution Channels
Transportation and Freight Infrastructure
Communications

Chinas Market Entry

Export to China
Indirect export
Direct Export
License and Contract Manufacture
Assembling in China
Contract Manufacturing
Trade Permit
Investment
Equity Joint Venture
Contractual Joint Venture
Wholly Foreign-Owned Enterprise

VII. MONOCLONAL ANTIBODY PRODUCER DIRECTORY

Profiles of Monoclonal Antibody Producers

LIST OF TABLES

I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. MONOCLONAL ANTIBODY INDUSTRY ASSESSMENTS
Monoclonal Antibody Sales Volume by Drugs Classification
Monoclonal Antibody Sales Volume
Major Producer Facility Location
Major Monoclonal Antibody Producer Sales Volume
Market Share of Key Producers
Major Foreign Investment in China

IV. MONOCLONAL ANTIBODY PRODUCTION AND DEMAND
Total Monoclonal Antibody Sales Volume
Monoclonal Antibody Major Producer and Their Market Share
Cancer Treatment Antibody Major Producer and Their Market Share
Autoimmunity Diseases Treatment Antibody Major Producer and
Their Market Share
Infection Treatment Antibody Major Producer and Their Market Share
Cardiovascular Diseases Treatment Antibody Major Producer and Their Market Share
Rejection of Organ Transplantation Treatment Antibody Major Producer and Their Market Share
Other Diseases Treatment Antibody Major Producer and Their Market Share
Monoclonal Antibody Import

V. MONOCLONAL ANTIBODY MARKET OUTLOOK
Consumer Spending Trend
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

Read More: Chinese Market

LIST OF CHARTS

I. INTRODUCTION

Monoclonal Antibody Sales Volume

II. BUSINESS ENVIRONMENT

Chinas GDP and Growth Rate
Industrial Output by Ownership
Chinas Imports and Exports

III. MONOCLONAL ANTIBODY INDUSTRY ASSESSMENTS

Monoclonal Antibody Sales Volume by Drugs Classification in 2008
Monoclonal Antibody Sales Volume
Monoclonal Antibody Production

IV. MONOCLONAL ANTIBODY PRODUCTION AND DEMAND

Total Monoclonal Antibody Sales Volume
Monoclonal Antibody Sales Volume by Classification in 2008
Worldwide Monoclonal Antibody Demand by Region
Cancer Treatment Antibody Sales Volume and Market Share
Autoimmunity Diseases Treatment Antibody Sales Volume and Market Share
Infection Treatment Antibody Sales Volume and Market Share
Cardiovascular Diseases Treatment Antibody Sales Volume and Market Share
Rejection of Organ Transplantation Treatment Antibody Sales Volume and Market Share
Other Diseases Treatment Antibody Sales Volume and Market Share
Monoclonal Antibody Import Volume
Monoclonal Antibody Import by Drugs Classification in 2008
Cancer Treatment Antibody Import Volume and Market Share
Autoimmunity Diseases Treatment Antibody Import Volume and Market Share
Infection Treatment Antibody Import Volume and Market Share
Cardiovascular Diseases Treatment Antibody Import Volume and Market Share
Rejection of Organ Transplantation Treatment Antibody Import Volume and Market Share
Other Diseases Treatment Antibody Import Volume and Market Share

V. MONOCLONAL ANTIBODY MARKET OUTLOOK
Total Monoclonal Antibody Sales Volume
VI. MARKETING STRATEGIES
Chinas Distribution Channel

To BUY This Report Kindly Visit Us @:

http://www.researchmoz.com/chinese-markets-for-monoclonal-antibody-report.html

Chinese Markets for Smoking Cessation Aids: Market Research Report

Chinese Markets for Smoking Cessation Aids

China's demand for Smoking Cessation Aids has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

Smoking Cessation Aids Industry Structure
Market Size
Market Growth Drivers
Smoking Cessation Aids Sales Volume
Major Producer Facility Locations
Major Producers Sales Volume and Market Share
Labor Cost
Potential Entrants
Development Trends
Major Distributors
Major Foreign Investment
Technology Development

Read More: Smoking Cessation Aids Market

IV. SMOKING CESSATION AIDS PRODUCTION AND DEMAND

Global Smoking Cessation Market
China Smoking Market Overview
China Smoking Cessation Aids Market Overview
China Smoking Cessation Aids Market Overview by Classification

Nicotine NRT
Nicotine Patch
Nicotine Gum/Tablets /Preparation
Nicotine Spray
Nicotine-Free Quit Aids
Bupropion
Varenicline Tartrate
Other Smoking Cessation Aids
Traditional Medicine
Vitamin C
Nitrous Oxide
Trimethoprim Furosemide UEA
Smoking Cessation Vaccine
Smoking Cessation Aids Import by Classification
Smoking Cessation Aids Export by Classification
Market Overview by Producers
Pricing Trend

V. SMOKING CESSATION AIDS MARKET OUTLOOK

Smoking Cessation Aids Markets Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

Read More: Chinese Market

VI. MARKETING STRATEGIES

China Market Entry Overview

Chinas Distribution System
Smoking Cessation Aids Distribution Channels
Transportation and Freight Infrastructure
Communications
Chinas Market Entry
Export to China
Indirect export
Direct Export
License and Contract Manufacture
Assembling in China
Contract Manufacturing
Trade Permit
Investment
Equity Joint Venture
Contractual Joint Venture
Wholly Foreign-Owned Enterprise

VII. SMOKING CESSATION AIDS PRODUCER DIRECTORY

Profiles of Smoking Cessation Aids Producer

LIST OF TABLES

I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. SMOKING CESSATION AIDS INDUSTRY ASSESSMENTS

Smoking Cessation Aids Sales Volume
Major Producer Facility Location
Major Smoking Cessation Aids Producer Sales Volume and Market Share
Major Foreign Investment in China

IV. SMOKING CESSATION AIDS PRODUCTION AND DEMAND

Smoking Cessation Aids Sales Volume by Classification
Smoking Cessation Aids Import by Drugs Classification
Smoking Cessation Aids Export by Drugs Classification
Smoking Cessation Aids Major Producer, Sales Volume, and Market Share
in 2008

V. SMOKING CESSATION AIDS MARKET OUTLOOK

Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

Smoking Cessation Aids Sales Volume

II. BUSINESS ENVIRONMENT

Chinas GDP and Growth Rate
Industrial Output by Ownership
Chinas Imports and Exports

III. SMOKING CESSATION AIDS INDUSTRY ASSESSMENTS

Total Smoking Cessation Aids Sales Volume
Smoking Cessation Aids Market Share by Drugs Classification in 2008
Smoking Cessation Aids Sales Volume

IV. SMOKING CESSATION AIDS PRODUCTION AND DEMAND

Smoking Cessation Aids Sales Volume
Smoking Cessation Aids Import
Smoking Cessation Aids Import by Country in 2008
Smoking Cessation Aids Export
Smoking Cessation Aids Market Share by Classification in 2008
Nicotine NRT Sales Volume and Market Share
Nicotine-Free Quit Aids Sales Volume and Market Share
Other Quit Smoking Aids Sales Volume and Market Share
Smoking Cessation Aids Import by Classification in 2008
Nicotine NRT Import Volume and Market Share
Nicotine-Free Quit Aids Import Volume and Market Share
Smoking Cessation Aids Export by Classification in 2008
Nicotine Patch Export Volume and Market Share
Electronic Cigarette Export Volume and Market Share
Smoking Cessation Perfume Export Volume and Market Share
Other Smoking Cessation Aids Export Volume and Market Share

VI. MARKETING STRATEGIES

Chinas Distribution Channel

To BUY This Report Kindly Visit Us @:

http://www.researchmoz.com/chinese-markets-for-smoking-cessation-aids-report.html

Chinese Markets for Disinfectants: Market Research Report

Chinese Markets for Disinfectants

China's demand for Disinfectants has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

TABLE OF CONTENTS

I. INTRODUCTION

Report Scope and Methodology
Executive Summary

II. BUSINESS ENVIRONMENT

Economic Outlook
Key Economic Indicators
Industrial Output
Population and Labor
Foreign Investment
Foreign Trade
Financial and Tax Regulations
Banking System and Regulations
Foreign Exchange
Taxes, Tariff and Custom Duties

III. DISINFECTANTS INDUSTRY ASSESSMENTS

Disinfectants Industry Structure
Market Size
Market Growth Drivers
Disinfectants Sales Volume
Major Producer Facility Locations and Sales Volume
Market Share of Key Producers
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investment
Technology Development

Read More: Disinfectants Market

IV. DISINFECTANTS PRODUCTION AND DEMAND

Overview
Demand of Disinfectants by Region
Disinfectants Sales Volume
Chlorine Disinfectants
Peroxide Disinfectants
Aldehyde Disinfectants
Alcohol Disinfectants
Iodine-containing Disinfectants
Phenolic Disinfectants
Epoxy Ethane
Biguanide Disinfectants
Quaternary Ammonium Disinfectants
Disinfectants Imports and Exports
Disinfectants Imports
Chlorine Disinfectants
Peroxide Disinfectants
Aldehyde Disinfectants
Alcohol Disinfectants
Iodine-containing Disinfectants
Phenolic Disinfectants
Epoxy Ethane
Biguanide Disinfectants
Quaternary Ammonium Disinfectants
Disinfectants Exports
Chlorine Disinfectants
Peroxide Disinfectants
Aldehyde Disinfectants
Alcohol Disinfectants
Iodine-containing Disinfectants
Phenolic Disinfectants
Epoxy Ethane
Biguanide Disinfectants
Quaternary Ammonium Disinfectants
Pricing Trends

V. DISINFECTANTS MARKET OUTLOOK

Disinfectants Market Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

VI. MARKETING STRATEGIES

China Market Entry Overview

Chinas Distribution System
Special Rubber Distribution Channels
Transportation and Freight Infrastructure
Communications

Chinas Market Entry

Export to China
Indirect export
Direct Export
License and Contract Manufacture
Assembling in China
Contract Manufacturing
Trade Permit
Investment
Equity Joint Venture
Contractual Joint Venture
Wholly Foreign-Owned Enterprise

Read More: Chinese Market

VII. DISINFECTANTS PRODUCER DIRECTORY

Disinfectants Producer Profiles
Distributors and Trading Companies
Research Institutions and Associations

LIST OF TABLES
I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. DISINFECTANTS INDUSTRY ASSESSMENTS

Disinfectants Sales Volume
China Disinfectants Manufacturers Distribution by Province
Major Producer Facility Location and Sales Volume
Major Disinfectants Producer Sales Volume
Market Share of Key Producers
Major Foreign Investment in China

IV. DISINFECTANTS PRODUCTION AND DEMAND

Total Disinfectants Sales Volume
Disinfectants Major Producer and Their Market Share
Chlorine Disinfectants Major Producer and Their Market Share
Peroxide Disinfectants Major Producer and Their Market Share
Aldehyde Disinfectants Major Producer and Their Market Share
Alcohol Disinfectants Major Producer and Their Market Share
Iodine-containing Disinfectants Major Producer and Their Market Share
Phenolic Disinfectants Major Producer and Their Market Share
Coagulation Factor Products Major Producer and Their Market Share
Coagulation Factor Products Sales Volume by Drugs Classification
Epoxy Ethane Major Producers and Their Market Share
Biguanide Disinfectants Major Producer and Their Market Share
Quaternary Ammonium Disinfectants Major Producer and Their Market Share
Disinfectants Import
Chinas Disinfectants Import by Country
Disinfectants Export

V. DISINFECTANTS MARKET OUTLOOK

Total Disinfectants Sales Volume
Consumer Spending Trend
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

LIST OF CHARTS

I. NTRODUCTION

Disinfectants Sales Volume

II. BUSINESS ENVIRONMENT

China's GDP and Industrial Output
Industrial Output by Ownership
Chinas Imports and Exports

III. DISINFECTANTS INDUSTRY ASSESSMENTS

Disinfectants Sales Volume
Chinas Key Disinfectants Producer Location by Province

IV. DISINFECTANTS PRODUCTION AND DEMAND

Disinfectants Sales Volume
Disinfectants Sales Volume by Classification
Worldwide Disinfectants Demand by Region
Chlorine Disinfectants Sales Volume and Market Share
Peroxide Disinfectants Sales Volume and Market Share
Aldehyde Disinfectants Sales Volume and Market Share
Alcohol Disinfectants Sales Volume and Market Share
Iodine-containing Disinfectants Sales Volume and Market Share
Phenolic Disinfectants Sales Volume and Market Share
Epoxy Ethane Sales Volume and Market Share
Biguanide Disinfectants Sales Volume and Market Share
Quaternary Ammonium Disinfectants Sales volume and Market Share
Disinfectants Import Volume
Disinfectants Import Volume by Classification
Chlorine Disinfectants Import and Market Share
Peroxide Disinfectants Import Volume and Market Share
Aldehyde Disinfectants Import Volume and Market Share
Alcohol Disinfectants Import Volume and Market Share
Iodine-containing Disinfectants Import Volume and Market Share
Phenolic Disinfectants Import Volume and Market Share
Epoxy Ethane Import Volume and Market Share
Biguanide Disinfectants Import Volume and Market Share
Quaternary Ammonium Disinfectants Import Volume and Market Share
Disinfectants Import by Country
Disinfectants Export Volume
Disinfectants Export Volume by Classification
Chlorine Disinfectants Export and Market Share
Peroxide Disinfectants Export Volume and Market Share
Aldehyde Disinfectants Export Volume and Market Share
Alcohol Disinfectants Export Volume and Market Share
Iodine-containing Disinfectants Export Volume and Market Share
Phenolic Disinfectants Export Volume and Market Share
Epoxy Ethane Export Volume and Market Share
Biguanide Disinfectants Export Volume and Market Share
Quaternary Ammonium Disinfectants Export Volume and Market Share
Chinas Disinfectants Import Price Trend 2007~2008

V. DISINFECTANTS MARKET OUTLOOK

Disinfectants Sales Volume by Drugs Classification

VI. MARKETING STRATEGIES

Chinas Distribution Channel

To BUY This Report Kindly Visit Us @:

http://www.researchmoz.com/chinese-markets-for-disinfectants-report.html

Chinese Markets for Wound Treatment: Market Research Report

Chinese Markets for Wound Treatment

China's demand for Wound Treatment has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

TABLE OF CONTENTS

I. INTRODUCTION

Wound Treatment Products Industry Structure
Market Size
Market Growth Drivers
Wound Treatment Products Sales Volume
Major Producer Facility Locations
Major Producers Sales Volume and Market Share
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investment
Technology Development

Read More: Wound Treatment Market

IV. WOUND TREATMENT PRODUCTION AND DEMAND

Wound Overview
Global Wound Treatment Market
China Wound Treatment Market Overview
Wound Treatment Products Market Overview by Classification
Wound Management Products
Adhesive Bandages and Tapes
Anti-Infective Wound Care
Wound Cleansing Agents
Debridement Agents
Instrumented Wound Healing
Pressure-Relief Equipment and Products
Moist Wound Healing Products
Biological Skins and Dressings

Wound-Closure Products
Hemostatic agents
Sutures
Wound Treatment Products Import by Classification
Wound Treatment Products Export by Classification
Market Overview by Producers
Pricing Trend

V. WOUND TREATMENT MARKET OUTLOOK

Wound Treatment Markets Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

VI. MARKETING STRATEGIES

China Market Entry Overview

Chinas Distribution System
Wound Treatment Products Distribution Channels
Transportation and Freight Infrastructure
Communications

Chinas Market Entry

Export to China
Indirect export
Direct Export
License and Contract Manufacture
Assembling in China
Contract Manufacturing
Trade Permit
Investment
Equity Joint Venture
Contractual Joint Venture
Wholly Foreign-Owned Enterprise

Read More: Chinese Market

VII. WOUND TREATMENT PRODUCER DIRECTORY

Profiles of Wound Treatment Products Producer

LIST OF TABLES

I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. WOUND TREATMENT INDUSTRY ASSESSMENTS

Wound Treatment Sales Volume
Major Producer Facility Location
Major Wound Treatment Products Producer Sales Volume and Market Share
Major Foreign Investment in China

IV. WOUND TREATMENT PRODUCTS PRODUCTION AND DEMAND

Top 10 Import Enterprise
Top 10 Export Enterprise
Wound Treatment Products Sales Volume by Classification
Wound Treatment Products Import by Drugs Classification
Wound Treatment Products Export by Classification
Wound Treatment Products Major Producer, Sales Volume, and Market Share in 2008

V. WOUND TREATMENT MARKET OUTLOOK

Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

Wound Treatment Products Sales Volume

II. BUSINESS ENVIRONMENT

Chinas GDP and Growth Rate
Industrial Output by Ownership
Chinas Imports and Exports

III. WOUND TREATMENT INDUSTRY ASSESSMENTS

Total Wound Treatment Product Sales Volume
Wound Treatment Product Market Share by Drugs Classification in 2008
Wound Treatment Product Sales Volume

IV. WOUND TREATMENT PRODUCTS PRODUCTION AND DEMAND

Wound Treatment Product Sales Volume
Wound Treatment Product Import
Wound Treatment Product Import by Country in 2008
Wound Treatment Product Export
Wound Treatment Product Export by Country in 2008
Wound Treatment Product Market Share by Classification in 2008
Wound Management Product Sales Volume
Adhesive Bandages and Tapes Sales Volume and Market Share
Anti-Infective Wound Care Sales Volume and Market Share
Wound Cleansing Agents Sales Volume and Market Share
Debridement Agents Sales Volume and Market Share
Instrumented Wound Healing Sales Volume and Market Share
Negative-pressure Wound Therapy (NPWT) Product Sales Volume and
Market Share
Moist Wound Healing Products Sales Volume and Market Share
Biological Skins and Dressings Sales Volume and Market Share
Wound-Closure Products Sales volume
Hemostatic Agents Sales Volume and Market Share
Sutures Sales Volume and Market Share
Wound Treatment Products Import by Classification in 2008
Diagnosis and Treatment Product Import Volume and Market Share
Disposable Medical Product Import Volume and Market Share
Medical Dressing Import Volume and Market Share
Dental Equipment and Materials Import Volume and Market Share
Health Rehabilitation Products Import Volume and Market Share
Wound Treatment Products Export by Classification in 2008
Wound Care Products Export Volume and Market Share
Wound-Closure Products Export Volume and Market Share

VI. MARKETING STRATEGIES

Chinas Distribution Channel

To BUY This Report Kindly Visit Us @:

http://www.researchmoz.com/chinese-markets-for-wound-treatment-report.html

Chinese Markets for Liver Cancer Treatment Drugs: Market Research Report

Chinese Markets for Liver Cancer Treatment Drugs

China's demand for Liver Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

Read More: Liver Cancer Treatment Drugs Market

IV. LIVER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Liver Cancer Overview
Global Liver Treatment Drugs Market Overview
Chinas Liver Treatment Market Overview by Classification
Chemotherapy Drug
Alkylating Agent
Antibiotics
Antimetabolites
Plant-originated Anticancer Drugs
Platinum Agent
Monoclonal Antibodies
Immunomodulator
Interferon alfa-2B
Interleukin -2
Group A streptococcus
BCG
Other Immunomodulator
Tradition Chinese Medicine
Other New Drugs
Liver Cancer Treatment Drugs Import and Export by Classification
Liver Cancer Treatment Drugs Import
Liver Cancer Treatment Drugs Export
Market Overview by Producers
Pricing Trend

V. LIVER CANCER TREATMENT DRUGS MARKET OUTLOOK

Liver Cancer Treatment Drugs Markets Outlook Overview
Government Regulation
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

VI. MARKETING STRATEGIES

China Market Entry Overview
Chinas Distribution System
Liver Cancer Treatment Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications
Chinas Market Entry
Export to China
Indirect export
Direct Export
License and Contract Manufacture
Assembling in China
Contract Manufacturing
Trade Permit
Investment
Equity Joint Venture
Contractual Joint Venture
Wholly Foreign-Owned Enterprise

Read More: Chinese Market

VII. LIVER CANCER TREATMENT DRUGS PRODUCER DIRECTORY

Profiles of Liver Cancer Treatment Drugs Producers

LIST OF TABLES

I. INTRODUCTION

Economic Outlook Summary

II. BUSINESS ENVIRONMENT

Key Economic Indicators
Industrial Output
Population and Labor Force Trends
Foreign Investment and Loans
Foreign Trade

III. LIVER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Liver Cancer Treatment Drugs Sales Volume
Major Producer Facility Location
Major Liver Cancer Treatment Drugs Producer Sales Volume and Their
Market Share in 2008
Major Foreign Investment in China

IV. LIVER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Liver Cancer Treatment Drugs Import by Country in 2008
Liver Cancer Treatment Drugs Export by Country in 2008
Liver Cancer Treatment Drugs Sales Volume by Drugs Classification
Liver Cancer Treatment Drugs Import by Drugs Classification
Liver Cancer Treatment Drugs Export by Drugs Classification
Liver Cancer Treatment Drugs Major Producer, Sales Volume, and Market Share in 2008

V. LIVER CANCER TREATMENT DRUGS MARKET OUTLOOK

Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

LIST OF CHARTS

I. INTRODUCTION

Liver Cancer Treatment Drugs Sales Volume

II. BUSINESS ENVIRONMENT

Chinas GDP and Growth Rate
Industrial Output by Ownership
Chinas Imports and Exports

III. LIVER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Liver Cancer Treatment Drugs Sales Volume
Liver Cancer Treatment Drugs Sales Volume by Drugs Classification in
2008

IV. LIVER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Liver Cancer Treatment Drugs Sales Volume
Liver Cancer Treatment Drugs Import
Liver Cancer Treatment Drugs Import by Country in 2008
Liver Cancer Treatment Drugs Export
Liver Cancer Treatment Drugs Export by Country in 2008
Liver Cancer Treatment Drugs Sales Volume by Classification in 2008
Chemotherapy Drug Sales Volume and Market Share
Immunomodulator Sales Volume and Market Share
Traditional Chinese Medicine Sales Volume and Market Share
Other New Drugs Sales Volume and Market Share
Liver Cancer Treatment Drugs Import by Classification in 2008
Chemotherapy Drug Import Volume and Market Share
Immunomodulator Import Volume and Market Share
Other New Drugs Import Volume and Market Share
Liver Cancer Treatment Drugs Export by Drugs Classification in 2008
Plant-originated Anticancer Drugs Export Volume and Market Share
Antibiotics Export Volume and Market Share
Antimetabolites Export Volume and Market Share
Traditional Chinese Medicine Export Volume and Market Share

VI. MARKETING STRATEGIES

Chinas Distribution Channel

To BUY This Report Kindly Visit Us @:

http://www.researchmoz.com/chinese-markets-for-liver-cancer-treatment-drugs-report.html

Chinese Markets for Kidney Cancer Treatment Drugs: Market Research Report

Chinese Markets for Kidney Cancer Treatment Drugs

China's demand for Kidney Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

TABLE OF CONTENTS

Read More: Kidney Cancer Treatment Drugs Market

III. KIDNEY CANCER TREATMENT DRUGS INDUSTRY
ASSESSMENTS

Kidney Cancer Treatment Drugs Industry Structure
Market Size
Market Growth Driver
Kidney Cancer Treatment Drugs Sales Volume
Major Producer Facility Locations
Major Producer Sales Volume and Market Share
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investments
Technology Development

IV. KIDNEY CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Overview
Sales Volume of Kidney Cancer Treatment Drugs by Region
Kidney Cancer Treatment Drugs Sales Volume

Chemotherapy Drugs Sales Volume
Alkylating Agents
Antimetabolites
Anti-Tumor Antibiotics
Steroids

Read More: Chinese Market

Immunotherapy Drug
Cytokines
Cancer Vaccines

Targeted Therapy Drugs Sales Volume
Monoclonal Antibody
Small Molecules Drug
Growth Factor Inhibitors

Kidney Cancer Treatment Drugs Imports and Exports
Pricing Trend

V. KIDNEY CANCER TREATMENT DRUGS MARKET OUTLOOK

Kidney Cancer Treatment Drugs Markets Outlook Overview
Government Regulations
Health Care Insurance Industry Overview
Consumer Spending Trends
Demographic Trends
Health Care Industry Trends
Hospitals and Hospital Beds
Physicians and Physician Visits

VI. MARKETING STRATEGIES

China Market Entry Overview
Chinas Distribution System
Kidney Cancer Treatment Drugs Distribution Channels
Transportation and Freight Infrastructure
Communications

Chinas Market Entry
Export to China
Indirect export
Direct Export
License and Contract Manufacture
Assembling in China
Contract Manufacturing
Trade Permit
Investment
Equity Joint Venture
Contractual Joint Venture
Wholly Foreign-Owned Enterprise

VII. KIDNEY CANCER TREATMENT DRUGS PRODUCER DIRECTORY

Kidney Cancer Treatment Drugs Producer Profiles and Directory
Major End-Users

To BUY This Report Kindly Visit Us @:

http://www.researchmoz.com/chinese-markets-for-kidney-cancer-treatment-drugs-report.html

Chinese Markets for Skin Cancer Treatment Drugs : Market Research Report

Chinese Markets for Skin Cancer Treatment Drugs

China's demand for Skin Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

Read More: Skin Cancer Treatment Market

Cancer Treatment Drugs Sales Volume
Major Producer Facility Locations and Sales Volume
Market Share of Key Producers
Labor Cost
Potential Entrants
Major Distributors
Major Foreign Investments
Technology Development

Read More: Chinese Market

IV. SKIN CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

Overview
Sales Volume of Skin Cancer Treatment Drugs by Region
Skin Cancer Treatment Drugs Sales Volume
Chemotherapy Drugs Sales Volume
Fluorouracil
Bleomycin
Cisplatin
Mitomycin
Retinoids
Immunotherapy Drug

To BUY This Report Kindly Visit Us @:

http://www.researchmoz.com/chinese-markets-for-skin-cancer-treatment-drugs-report.html

Personal Care Market- Global Analysis And Forecast, 2011 - 2017

Personal Care Market- Global Analysis and Forecast, 2011 – 2017

The study contains market forecasts for personal care product segments that include Personal Hygiene, Make-Up, Bath & Shower, Deodorants, Skin Care, Fragrances, Hair care, Oral Hygiene and other Personal Products. Market has been also segmented based on various geographies that covers various key markets.

Browse : Personal Care Market

The Global skin care and deodorants market is witnessing healthy growth rate for last few years and expected to do so for next few years. The major market drivers for personal care industry include innovative product offering, increased disposable incomes, and higher market penetration. Developing economies are witnessing robust growth rate and enjoying the continuously increasing usage of personal care product, as the spending power and awareness for the health benefits of hygiene are growing in these regions

Emerging Pharmaceutical Market in Brazil - Regulatory Framework Forces MNCs to Partner with Local Players Resulting in Profit and Control Sharing

Emerging Pharmaceutical Market in Brazil - Regulatory Framework Forces MNCs to Partner with Local Players Resulting in Profit and Control Sharing

Emerging Pharmaceutical Market in Brazil

GBI Researchs new report, Emerging Pharmaceutical Market in Brazil - Regulatory Framework Forces MNCs to Partner with Local Players Resulting in Profit and Control Sharing provides an in-depth analysis of the trends, issues and challenges in the pharmaceutical market in Brazil. The report analyzes the overall pharmaceutical and outsourcing market structure of the country. The report provides competitive benchmarking for the leading companies and analyzes the M&A and strategic partnerships that shape the Brazilian pharmaceutical market. The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

The Brazilian pharmaceutical market is one of the top emerging markets globally. In terms of revenue it is the seventh largest market in the world and the largest in Latin America. Since the introduction of the new Patent Law in 1997, many foreign pharmaceutical companies have entered the Brazilian market. However, due to the lack of government support in the country, these companies (MNCs) have mostly partnered with local players for the expansion of their services.

GBI Research analysis shows that generics have achieved higher growth in the market due to legal and regulatory support. The generics accounted for 20.6% of the market share in 2011 and are expected to grow in future. Both private and public sectors are playing a role in the healthcare infrastructure of the country. The availability of reasonably priced raw materials and good access to the patient pool, well-equipped facilities, high-quality staff and infrastructure are the major attractions for foreign players.

The Brazilian pharmaceutical market grew at a CAGR (Compound Annual Growth Rate) of 9% between 2004 and 2010. The economic growth of the country was above the world average and inflation was low compared to Argentina and Paraguay. In accordance with the Brazilian Ministry of Health, the private healthcare sector contributes approximately 2% of Brazils GDP.

According to GBI Researchs analysis, the Brazilian pharmaceutical market poses a number of challenges due to its diverse nature, which creates difficulties in terms of understanding the characteristics of sub-regions. The major challenge for foreign players planning to enter the market is the legal framework of the country. This forces the companies into partnering with local companies, resulting in profit and control sharing. The legal and regulatory framework for patents is limited, leading to a lack of protection for intellectual property rights. This tends to result in difficulties for companies spending on R&D.

Scope

The overall pharmaceutical, biotech and outsourcing market structure in Brazil
A market characterization of the Brazilian pharmaceutical market, including market size, major regulatory bodies, pricing and reimbursement issues, major distribution channels and intellectual property rights.
Brazilian CRO market growth
Analysis of the leading segments within the Brazilian pharmaceutical industry
Market drivers and restraints that have a significant impact on the market.
Competitive benchmarking of the leading companies in the pharmaceutical and CRO markets.
Key M&A activities and strategic partnership deals that have taken place between 2004 and mid-2011.

Reasons to buy

Develop market-entry and market expansion strategies by identifying the leading emerging markets poised for strong growth.
Develop a tailored country strategy through the understanding of key drivers and barriers of each countrys pharmaceutical market.
Develop key strategic initiatives by understanding the key focus areas of leading companies.
Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships.

· Table of Contents

· 1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 8

·
2 Emerging Pharmaceutical Market: Brazil - Introduction 10

·
3 Emerging Pharmaceutical Market: Brazil - Industry Characterstics 11
3.1 Market Size and Market Forecast 11
3.2 Market Share by Therapy Area 12
3.3 Branded versus Generic Market Share 13
3.4 R&D Expenditure Innovations 14
3.4.1 Increased Screening Rates during R&D 14
3.5 Top Pharmaceutical Companies in Brazil 15
3.5.1 Domestic Players 15
3.5.2 Foreign Players 20
3.6 Drivers and Challenges 24
3.6.1 Drivers 24
3.6.2 Barriers 25
3.7 Healthcare Delivery System 26
3.7.1 Brazil Healthcare Delivery Opportunities 26
3.7.2 Brazil Healthcare Delivery Challenges 28
3.8 PESTLE Analysis 29
3.8.1 Political factors 29
3.8.2 Economic factors 29
3.8.3 Social factors 29
3.8.4 Technological factors 30
3.8.5 Legal factors 30
3.8.6 Environmental factors 30

·
4 Emerging Pharmaceutical Market: Brazil - Macroeconomic Environment 31
4.1 Demographic Analysis 31
4.1.1 Population Size, Growth, and Structure 31
4.1.2 Disease Overview in Brazil 34
4.2 GDP 39
4.3 Per Capita Income 41
4.3.1 Context 41
4.3.2 Analytical Framework 41
4.4 Healthcare Expenditure 42
4.4.1 Context 42
4.4.2 Analytical Framework 43
4.5 Healthcare Infrastructure 44
4.5.1 Analytical Framework 45

·
5 Emerging Pharmaceutical Market: Brazil -Healthcare Regulation 47
5.1 Pharmaceutical Regulation in Brazil 47
5.2 Drug Approval Process 47
5.3 Drug Registration Process 48
5.4 Patents and Generics (IPR) 49
5.5 Health Insurance Coverage 50
5.6 Clinical Trials 50
5.6.1 Context 50
5.6.2 Analytical Framework 51
5.7 Pricing and Reimbursement 51
5.7.2 Hospotels 55
5.7.3 Cosmetic Travel 55
5.8 Regulatory Bodies 56
5.8.1 Ministry of Health (MOH) 56
5.8.2 Unified Health System (UHS also called as SUS in Brazil) 57

·
6 Emerging Pharmaceutical Market: Brazil - Industry Trends 58
6.1 Mergers and Acquisitions 58
6.1.1 M&A Deals by Year 58
6.1.2 Deal by Value 59
6.1.3 Recent M&A Deals 60
6.1.4 Top Five M&As 60
6.2 Co-development Deals 61
6.2.1 Deals by Year 61
6.2.2 Deal by Value 62
6.2.3 Recent Co-development Deals 62
6.2.4 Top Co-development Deals 63
6.3 Licensing Agreements 64
6.3.1 Deals by Year 64
6.3.2 Deals by Value 65
6.3.3 Recent Licensing Agreements 65
6.3.4 Top Licensing Agreements 66

·
7 Emerging Pharmaceutical Market: Brazil - CRO Industry 67
7.1 Contract Research Organization (CRO) Market Size and Growth 67
7.1.1 PPD 67
7.1.2 PRA International 69
7.1.3 ICON 70
7.1.4 Theorem Clinical Research 71
7.1.5 PAREXEL 72
7.1.6 Intrials 73
7.1.7 Eurotrials 74
7.1.8 PGS Medical/Statistics 75
7.1.9 INC Research 76
7.1.10 Chiltern 77
7.1.11 Covance 78
7.1.12 Quintiles 79

·
8 Emerging Pharmaceutical Market: Brazil - Appendix 80
8.1 Market Definitions 80
8.2 Abbreviations 80
8.3 Sources 80
8.4 Research Methodology 81
8.4.1 Industry Performance 81
8.4.2 Macroeconomic Environment 81
8.4.3 Healthcare Regulations 82
8.4.4 Industry Trends 82
8.5 Contact Us 82
8.6 Disclaimer 82

· List of Table:

·
Table 1: Emerging Pharmaceutical Market: Brazil, Revenue, $bn, 2004-2010 11
Table 2: Emerging Pharmaceutical Market: Brazil, Revenue Forecasts, $bn, 2010-2018 11
Table 3: Emerging Pharmaceutical Market: Brazil, Population Age Structure, (%) ,1950-2050 31
Table 4: Emerging Pharmaceutical Market in Brazil, Population Forecast of Brazil, (Million), 2005-2050 33
Table 5: Emerging Pharmaceutical Market: Brazil, Number of Deaths by Major Diseases, (%), 2008 34
Table 6: Emerging Pharmaceutical Market: Brazil, Population Forecast for HIV/AIDS Prevalence (000), 2010-2018 35
Table 7: Emerging Pharmaceutical Market: Brazil, Population Forecast for CVD Prevalence (Million), 2010-2018 36
Table 8: Emerging Pharmaceutical Market: Brazil, Population Forecast for Diabetes Prevalence (Million), 2010-2018 37
Table 9: Emerging Pharmaceutical Market: Brazil, Population Forecast for Cancer Prevalence (000), 2010-2018 38
Table 10: Emerging Pharmaceutical Market: Brazil, GDP Results at Market Prices from 1Q-2010 to 1Q- 2011 39
Table 11: Emerging Pharmaceutical Market: Brazil, Per Capita Income, ($), 1999-2010 41
Table 12: Emerging Pharmaceutical Market: Brazil, Comparative Analysis of Healthcare Expenditure Ratios, Argentina, Mexico and BRIC Countries (%), 2009 41
Table 13: Emerging Pharmaceutical Market: Brazil, Public and Private Distribution, (%), 2008 44
Table 14: Emerging Pharmaceutical Market: Brazil, Healthcare Infrastructure, 2008 45
Table 15: Emerging Pharmaceutical Market - Brazil, Documents Required for Product Registration by ANVISA 49
Table 16: Emerging Pharmaceutical Market - Brazil, Clinical Trials Market, ($m), 2010-2018 50
Table 17: Emerging Pharmaceutical Market - Brazil, Number of Plan Members and Revenue, ($bn), 2010 54
Table 18: Emerging Pharmaceutical Market - Brazil, Private Healthcare Coverage Providers, Number of Plan Members and Revenue, ($m), 2010 55
Table 19: Emerging Pharmaceutical Market - Brazil, Surgeries, Cost Comparison, the US and Brazil ($), 2009 55
Table 20: Emerging Pharmaceutical Market - Brazil, Recent M&A Deals, 2009-2011 60
Table 21: Emerging Pharmaceutical Market - Brazil, Recent Co-development Deals, 2011 62
Table 22: Emerging Pharmaceutical Market - Brazil, Recent Licensing Agreements, 2011 65

· List of Charts:

·
Figure 1: Emerging Pharmaceutical Market: Brazil, Revenue Forecast, $bn, 2004-2018 11
Figure 2: Emerging Pharmaceutical Market: Brazil, Market Share by Therapy Area, (%), 2010 12
Figure 3: Emerging Pharmaceutical Market: Brazil, R&D Restructuring Activities, 2010 14
Figure 4: Emerging Pharmaceutical Market - Brazil, Key Domestic Players, EMS Sigma Pharma , SWOT Profile, 2010 15
Figure 5: Emerging Pharmaceutical Market - Brazil, Key Domestic Players, Ache Laboratorios Farmaceuticos, SWOT Profile, 2010 16
Figure 6: Emerging Pharmaceutical Market - Brazil, Key Domestic Players, Eurofarma, SWOT Profile, 2010 17
Figure 7: Emerging Pharmaceutical Market - Brazil, Key Domestic Players, Medley Pharmaceuticals, SWOT Profile, 2010 18
Figure 8: Emerging Pharmaceutical Market - Brazil, Key Domestic Players, Hypermarcas, SWOT Profile, 2010 19
Figure 9: Emerging Pharmaceutical Market - Brazil, Key Foreign Players, Sanofi, SWOT Profile, 2010 20
Figure 10: Emerging Pharmaceutical Market - Brazil, Key Foreign Players, Novartis, SWOT Profile, 2010 21
Figure 11: Emerging Pharmaceutical Market - Brazil, Key Foreign Players, Pfizer, SWOT Profile, 2010 22
Figure 12: Emerging Pharmaceutical Market - Brazil, Key Foreign Players, Roche, SWOT Profile, 2010 23
Figure 13: Emerging Pharmaceutical Market: Brazil, Drivers and Barriers in the Brazilian Pharmaceutical Market 24
Figure 14: Emerging Pharmaceutical Market: Brazil, Healthcare Delivery Opportunities, 2010 26
Figure 15: Emerging Pharmaceutical Market: Brazil, Healthcare Delivery Barriers, 2010 28
Figure 16: Emerging Pharmaceutical Market: Brazil, PESTLE Analysis 29
Figure 17: Emerging Pharmaceutical Market: Brazil, Population Age Structure, (%), 1950-2050 31
Figure 18: Emerging Pharmaceutical Market: Brazil, Health Indicators, 2011 32
Figure 19: Emerging Pharmaceutical Market in Brazil, Population Forecast of Brazil, (Million), 2005-2050 33
Figure 20: Emerging Pharmaceutical Market: Brazil, Number of Deaths by Major Diseases, (%), 2008 34
Figure 21: Emerging Pharmaceutical Market: Brazil, Population Forecast for HIV/AIDS Prevalence (000), 2010-2018 35
Figure 22: Emerging Pharmaceutical Market: Brazil, Population Forecast for CVD Prevalence (Million), 2010-2018 36
Figure 23: Emerging Pharmaceutical Market: Brazil, Population Forecast for Diabetes Prevalence (Million), 2010-2018 37
Figure 24: Emerging Pharmaceutical Market: Brazil, Population Forecast for Cancer Prevalence (000), 2010-2018 38
Figure 25: Emerging Pharmaceutical Market: Brazil, GDP Composition by Sector (%), 2010 39
Figure 26: Emerging Pharmaceutical Market: Brazil, GDP and Inflation Rates, 2005-2011 40
Figure 27: Emerging Pharmaceutical Market: Brazil, National Healthcare Expenditure, (% of GDP), 2008 42
Figure 28: Emerging Pharmaceutical Market: Brazil, Comparative Analysis of Healthcare Expenditure Ratios, Argentina, Mexico and BRIC Countries, (%), 2009 43
Figure 29: Emerging Pharmaceutical Market: Brazil, Public and Private Distribution, (%), 2008 44
Figure 30: Emerging Pharmaceutical Market: Brazil, Healthcare Infrastructure, 2008 45
Figure 31: Emerging Pharmaceutical Market: Brazil, Healthcare Professionals, (%), 2008 46
Figure 32: Emerging Pharmaceutical Market: Brazil, Hospitals, by Bed Distribution, (%), 2008 46
Figure 33: Emerging Pharmaceutical Market: Brazil, Regulatory Approval Process for Clinical Trials 47
Figure 34: Emerging Pharmaceutical Market: Brazil, Drug Registration Process by ANVISA 48
Figure 35: Emerging Pharmaceutical Market - Brazil, Clinical Trial Market, ($m), 2010-2018 50
Figure 36: Emerging Pharmaceutical Market - Brazil, Reimbursement, 2009 51
Figure 37: Emerging Pharmaceutical Market - Brazil, Healthcare Coverage Providers, Plan Members, (%), 2010 53
Figure 38: Emerging Pharmaceutical Market - Brazil, Healthcare Coverage Providers, Revenue, (%), 2010 54
Figure 39: Emerging Pharmaceutical Market - Brazil, M&A Deals by Year, 2004-2011 58
Figure 40: Emerging Pharmaceutical Market - Brazil, M&A Deals by Value, (%), 2004-2011 59
Figure 41: Emerging Pharmaceutical Market - Brazil, Co-development Deals by Year, 2004-2011 61
Figure 42: Emerging Pharmaceutical Market - Brazil, Co-development Deals by Value, (%), 2004-2011 62
Figure 43: Emerging Pharmaceutical Market - Brazil, Licensing Agreements by Year, 2004-2011 64
Figure 44: Emerging Pharmaceutical Market - Brazil, Licensing Agreements by Value, (%), 2004-2011 65
Figure 45: Emerging Pharmaceutical Market - Brazil, PPD, Company Profile, 2011 67
Figure 46: Emerging Pharmaceutical Market - Brazil, PRA International, Company Profile, 2011 69
Figure 47: Emerging Pharmaceutical Market - Brazil, ICON, Company Profile, 2011 70
Figure 48: Emerging Pharmaceutical Market - Brazil, Theorem Clinical Research, Company Profile, 2011 71
Figure 49: Emerging Pharmaceutical Market - Brazil, PAREXEL, Company Profile, 2011 72
Figure 50: Emerging Pharmaceutical Market - Brazil, Intrials, Company Profile, 2011 73
Figure 51: Emerging Pharmaceutical Market - Brazil, Eurotrials, Company Profile, 2011 74
Figure 52: Emerging Pharmaceutical Market - Brazil, PGS Medical/Statistics, Company Profile, 2011 75
Figure 53: Emerging Pharmaceutical Market - Brazil, INC Research, Company Profile, 2011 76
Figure 54: Emerging Pharmaceutical Market - Brazil, Chiltern, Company Profile, 2011 77
Figure 55: Emerging Pharmaceutical Market - Brazil, Covance, Company Profile, 2011 78
Figure 56: Emerging Pharmaceutical Market - Brazil, Quintiles, Company Profile, 2011 79

Emerging Pharmaceutical Market in Brazil - Regulatory Framework Forces MNCs to Partner with Local Players Resulting in Profit and Control Sharing

Emerging Pharmaceutical Market in Brazil

Blog Archive